Revolution Medicines
Develops RAS(ON) therapeutics for KRAS-driven and broad RAS-driven solid tumors.
$208.55
After-hours close+0.48 (+0.23%)
At close$208.07(−5.91%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.44 | — | — |
| Aug 2026 | −$2.04 | −$3.06 | −50.0% |
| May 2026 | −$1.84 | −$2.29 | −24.5% |
| Feb 2026 | −$1.58 | −$1.86 | −17.7% |
| Nov 2025 | −$1.42 | −$1.61 | −13.4% |
The latest year is open to everyone — the 27 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Feb 2020 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$2.44 | — | — | $13.4M | — | — |
| Aug 5, 2026 | −$2.04 | −$3.06 | −50.0% | $1.8M | — | — |
| May 6, 2026 | −$1.84 | −$2.29 | −24.5% | $2.4M | — | — |
| Feb 25, 2026 | −$1.58 | −$1.86 | −17.7% | $3.7M | — | — |
| Nov 5, 2025 | −$1.42 | −$1.61 | −13.4% | $1.7M | — | — |
The latest year is open to everyone — the 27 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 7, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 26, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 27, 2023 | ||||||
| Nov 7, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 11, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 2, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 14, 2020 | ||||||
| Mar 30, 2020 | ||||||
| Feb 13, 2020 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Dec 31, 2018 | ||||||